跳转至内容
Merck
CN

SCNY00100

Millipore® Steriflip® 真空管顶过滤器

pore size 100.0 μm, Nylon membrane (net), funnel capacity 50 mL, pack of 25 ea

别名:

Steriflip®无菌离心管顶部过滤装置

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
41104914
NACRES:
NB.22
eCl@ss:
32031602
Material:
Nylon membrane (net), acrylic housing, polypropylene
Pore size:
100.0 μm pore size
Working volume:
50 mL
Sterility:
sterile
Packaging:
pack of 25 ea
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Level

material

Nylon membrane (net), acrylic housing, polypropylene

sterility

sterile

product line

Steriflip®

feature

holdup volume 0.6 mL, hydrophilic

packaging

pack of 25 ea

parameter

45 °C max. temp.

technique(s)

sterile filtration: suitable

H

138 mm

diam.

6.4 cm

filter diam.

4 cm

filtration area

7 cm2

funnel capacity

50 mL

working volume

50 mL

pore size

100.0 μm pore size

fitting

double lead thread inlet (with vacuum port), double lead thread outlet for 50 mL centrifuge tube

shipped in

ambient

storage temp.

15-25°C

General description

Steriflip® 过滤装置可分离较大体积的细胞材料,其附加优势在于可维持无菌环境,确保样品无菌性,这一点是开口式重力流过滤设备无法保证的。Steriflip无菌离心管顶部过滤装置可以让细胞通过同时截留大的组织块。这提高了回收率并减少了收集分离的细胞的时间。

Application

仅限研究用途。
Steriflip®无菌离心管顶过滤器已用于肿瘤获取和处理。它还用于从Balb/c小鼠提取的心脏中分离心脏干细胞(CSC)。

Legal Information

Millipore is a registered trademark of Merck KGaA, Darmstadt, Germany
Steriflip is a registered trademark of Merck KGaA, Darmstadt, Germany


Still not finding the right product?




分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


商品

可生成组织和干细胞来源3D脑、胃肠道、肺和癌症肿瘤类器官模型的类器官培养产品。

Organoid culture products to generate tissue and stem cell derived 3D brain, intestinal, gut, lung and cancer tumor organoid models.

Select the right sterile filter by media, volume, and application.

相关内容

The isolation and expansion of cardiac stem cells opens new opportunities to the feld of cardiac regenerative medicine. CSCs have recently been isolated from human and murine tissues based upon cell biomarkers (Sca-1, TERT, c-Kit, side population), demonstrating the presence of a non-circulating stem cell niche within the myocardium that is estimated to account for 11-14% of the total cell population1. These cells appear to be bi-potent in their capacity to form cardiomyocytes and vascular endothelial cells. Moreover, preliminary engraftment studies suggest that these cells are ideal candidates for future research on cardiac regeneration. However, the rarity of CSCs coupled with the complex isolation procedure is a signifcant challenge for the advancement of the field. o overcome this obstacle, we have developed an easy-to-use cell isolation kit capable of obtaining a high yield, pure population of CSCs. This advancement allows investigators to obtain a signifcantly greater number of CSCs for their studies without the need for time consuming, complex protocols and expensive cell sorting equipment.

查看所有相关内容

Steven D Forsythe et al.
Annals of surgical oncology, 27(13), 4950-4960 (2020-07-08)
Chemotherapy dosing duration and perfusion temperature vary significantly in HIPEC protocols. This study investigates patient-derived tumor organoids as a platform to identify the most efficacious perfusion protocol in a personalized approach. Peritoneal tumor tissue from 15 appendiceal and 8 colon



全球贸易项目编号

货号GTIN
SCNY0010004053252504433